International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 3 , Pages 821-827 , 1 November 2010

Concurrent Chemoradiotherapy With Paclitaxel and Nedaplatin Followed by Consolidation Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix: Preliminary Results of a Phase II Study

  • Mei-Qin Zhang, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Mei-Qin Zhang, M.D., Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-an Road, Shanghai 200032, P.R. China. Tel: (86) 21-64175590, ext. 2905; Fax: (86) 21-64174774
    • ,
  • Su-Ping Liu, M.D.
    • ,
  • Xiang-E. Wang, M.B.

Received 18 March 2009 ,Revised 31 August 2009 ,Accepted 31 August 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Whitney CW, Sause W, Bundy BN, et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339–1348
  3. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–1153
  4. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–1161
  5. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med. 1999;340:1137–1143
  6. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet. 2001;358:781–786
  7. Lucca H, Hirte H, Fyles A, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: A meta-analysis. Clin Oncol. 2002;14:203–212
  8. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26:5802–5811
  9. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872–880
  10. McGuire WP, Blessing JA, Moore DH, et al. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol. 1996;14:792–795
  11. Rodriguez M, Sevin BU, Perras J, et al. Paclitaxel: A radiation sensitizer of human cervical cancer cells. Gynecol Oncol. 1995;57:165–169
  12. Kato T, Nishimura H, Yakushiji M, et al. Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer. Gan to Kagaku Ryoho. 1992;19:695–701
  13. Follen M, Levenback CF, Iyer RB, et al. Imaging in cervical cancer. Cancer. 2003;98:2028–2038
  14. Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006;106:914–922
  15. Girardi F, Petru E, Heydarfadai M, et al. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol. 1993;49:177–180
  16. Ayhan A, Tuncer ZS, Tuncer R, et al. Tumor status of lymph nodes in early endometrial cancer in relation to lymph need size. Eur J Obstet Gynecol Biol. 1995;60:61–63
  17. Thigpen T, Vance RT, Kansur T. The platinum compounds and paclitaxel in the management of carcinoma of the endometrium and the uterine cervix. Semin Oncol. 1995;22(Suppl12):67–72
  18. Hartmann JT, Lipp HP. Toxicity of platinum compounds. Expert Opin Pharmacother. 2003;4:889–901
  19. Hasegawa Y, Takanashi S, Okudera K, et al. Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: A phase I/II study. Jpn J Clin Oncol. 2004;34:647–653
  20. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  21. Choi CH, Lee JW, Kim TJ, et al. Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results. Int J Radiat Oncol Biol Phys. 2007;68:817–822
  22. Flueckiger F, Ebner F, Poschauko H, et al. Cervical cancer: Serial MR imaging before and after primary radiation therapy—A 2-year follow-up study. Radiology. 1992;184:89–93
  23. Hatano K, Sekiya Y, Araki H, et al. Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1999;45:639–644
  24. Berman ML, Keys H, Creasman W, et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984;19:8–16
  25. Wong LC, Ngan HY, Cheung AN, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol. 1999;17:2055–2060
  26. Vrdoljak E, Prskalo T, Omrcen T, et al. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study. Int J Radiat Oncol Biol Phys. 2005;61:824–829
  27. Lorvidhaya V, Chitapanarux I, Sangruchi S, et al. Concurrent mitomycin C, 5-Fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial. Int J Radiat Oncol Biol Phys. 2003;55:1226–1232
  28. Lee MY, Wu HG, Kim K, et al. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2007;104:95–99
  29. Spensley S, Hunter RD, Livsey JE, et al. Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Clin Oncol. 2009;21:49–55

 Supported by Shanghai Municipality Bureau of Health Grant 034092 (to Mei-Qin Zhang).

 Conflict of interest: none.

PII: S0360-3016(09)03043-0

doi: 10.1016/j.ijrobp.2009.08.069

International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 3 , Pages 821-827 , 1 November 2010

Article Tools

* Image Usage & Resolution